{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"IO Biotech, Inc."},"Symbol":{"label":"Symbol","value":"IOBT"},"Address":{"label":"Address","value":"OLE MAALOES VEJ 3,OLE MAALOES VEJ 3, COPENHAGEN N, DK-2200, Denmark"},"Phone":{"label":"Phone","value":"+45 70702980"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression."},"CompanyUrl":{"label":"Company Url","value":"https://www.iobiotech.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Diane McDowell","title":"SVP-Clinical Development & Medical Affairs"},{"name":"Eric Faulkner","title":"Chief Technical Officer"},{"name":"Mai-Britt Zocca","title":"President, Chief Executive Officer & Director"},{"name":"Muhammad Al-Hajj","title":"Chief Scientific Officer"},{"name":"Qasim Ahmad","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}